Anti-PDCD1/PD-1/CD279 Antibody (Prolgolimab)
Catalog No.
F1334
Anti-PDCD1/PD-1/CD279 Antibody (Prolgolimab)
Featured Products
Prolgolimab (BCD-100) is aIgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing "LALA" mutation. Prolgolimab is being investigated in advanced melanoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2093956-19-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Forteca, BCD-100
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized Human PDCD1/PD-1/CD279, Fc Tag can bind Anti-PDCD1/PD-1/CD279 Antibody (Prolgolimab), The EC50 was approximately 0.02294 ug/mL.
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.